Free cash flow generation has been volatile, swinging from a negative $13.3M in 2024Q1 to a positive $79.6M in 2026Q2, with working capital changes being the primary driver of quarterly cash flow variability.
Aveanna Healthcare Holdings Inc. (AVAH) cash flow statement — 8-year operating, investing & financing cash flows
| Metric | TTM | Jan'26 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 |
|---|
| Cash from Operations | 168.2M | 122.24M | 32.64M | 22.67M | -48.4M | -11.35M | 116.62M | -8.71M | 21.6M |
| Operating CF Margin % | - | 5.02% | 1.61% | 1.2% | -2.71% | -0.68% | 7.8% | -0.63% | 1.72% |
| Operating CF Growth % | 491.14% | 274.54% | 43.95% | 146.84% | -326.45% | -109.73% | 1438.28% | -140.35% | - |
| Net Income | 274.76M | 225.03M | -10.93M | -134.52M | -662.03M | -117.04M | -57.05M | -76.52M | -47.15M |
| Depreciation & Amortization | -2.43M | 28.22M | 31.16M | 30.1M | 38.82M | 35.39M | 30.22M | 27.01M | 11.94M |
| Stock-Based Compensation | -12.01M | 0 | 17.46M | 13.16M | 15.89M | 14.43M | 3.27M | 1.95M | 2.12M |
| Deferred Taxes | -607K | -143.03M | 1.03M | 1.01M | -115K | 1.31M | -6.42M | -919K | -3.63M |
| Other Non-Cash Items | -111.74M | 64.67M | 23.87M | 136.32M | 601.26M | 125.89M | 90.06M | 26.7M | 23.56M |
| Working Capital Changes | 20.22M | -52.66M | -29.97M | -23.4M | -42.22M | -71.33M | 56.54M | 13.06M | 34.76M |
| Change in Receivables | 18.21M | -30.22M | -28.64M | -15.32M | -3.23M | -8.81M | 8.56M | 3.34M | -7.96M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | -27.06M | 0 | -13.2M | 15.4M |
| Change in Payables | -5.65M | -6.23M | 6.45M | -13.92M | -3.92M | -11.7M | -6.81M | 19.29M | 21.51M |
| Cash from Investing | -183.89M | -22.3M | -6.32M | -8.79M | -25.29M | -681.83M | -193.54M | -17.82M | -229.55M |
| Capital Expenditures | -2.37M | -7.45M | -6.32M | -6.12M | -12.01M | -15.95M | -15.24M | -16.64M | -19.58M |
| CapEx % of Revenue | 0.09% | 0.31% | 0.31% | 0.32% | 0.67% | 0.95% | 1.02% | 1.2% | 1.56% |
| Acquisitions | -154.59M | -14.85M | 0 | 0 | -1.55M | -666.91M | -178.31M | -1.19M | -209.97M |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -26.93M | 0 | 0 | -2.68M | -11.27M | 0 | 0 | 0 | 0 |
| Cash from Financing | 12.15M | 9.03M | 14.03M | 10.85M | 62.42M | 586.33M | 210.94M | 21.86M | 204.15M |
| Debt Issued (Net) | 413K | -3.76M | -2.36M | -5.73M | 60.15M | 161.59M | 136.69M | 68.94M | 149.73M |
| Equity Issued (Net) | 3.09M | 6.52M | 3.09M | 945K | 4.01M | 477.69M | 50M | 0 | 54.42M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 4.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 8.65M | 6.27M | 13.3M | 15.63M | -1.74M | -52.95M | 24.25M | -47.07M | 0 |
| Net Change in Cash | -3.54M | 108.97M | 40.35M | 24.73M | -11.27M | -106.86M | 134.02M | -4.67M | -3.8M |
| Free Cash Flow | 165.83M | 114.79M | 26.32M | 16.56M | -60.41M | -27.3M | 101.38M | -25.35M | 2.02M |
| FCF Margin % | 6.37% | 4.72% | 1.3% | 0.87% | -3.38% | -1.63% | 6.78% | -1.83% | 0.16% |
| FCF Growth % | 111.2% | 336.17% | 58.96% | 127.4% | -121.3% | -126.93% | 499.91% | -1356.87% | - |
| FCF per Share | 0.74 | 0.53 | 0.14 | 0.09 | -0.33 | -0.15 | 0.55 | -0.14 | 0.01 |
| FCF Conversion (FCF/Net Income) | 0.60x | 0.54x | -2.99x | -0.17x | 0.07x | 0.10x | -2.04x | 0.11x | -0.46x |
| Interest Paid | -34.28M | 0 | 152.51M | 137.85M | 102.53M | 58.96M | 73.05M | 92.81M | 62.77M |
| Taxes Paid | 0 | 0 | 5.71M | 1.14M | 1.59M | 5.28M | 2.17M | 1.55M | 3.15M |
Quick answers to the most common questions about buying AVAH stock.
Aveanna Healthcare Holdings Inc. (AVAH) generated $122.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Aveanna Healthcare Holdings Inc. (AVAH) generated $114.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Aveanna Healthcare Holdings Inc. (AVAH) spent $7.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
Key Metrics
Top Statement Risk
Leverage and cash flow volatility
Metrics are mathematically derived from official filings.
Earnings Quality Masked by Working Capital Swings
The relationship between net income and operating cash flow is highly erratic, with the OCF/NI ratio swinging from -1.66 to 2.36 over the past ten quarters, indicating that reported earnings are a poor proxy for underlying cash generation.
The wide dispersion in the OCF/NI ratio suggests that non-cash items and, more importantly, volatile working capital movements are the primary drivers of reported cash flow. For instance, in 2026Q1, a $41.7M net income translated to just $4.3M in operating cash flow due to a $50.7M working capital outflow, while in 2025Q3, a $14.1M net income generated $33.2M in cash. This pattern implies that the timing of Medicaid reimbursements and payables management create significant quarterly noise, obscuring the true cash conversion quality of the core business.
FCF Volatility Undermines Growth Narrative
Free cash flow has been inconsistent, ranging from a negative $13.3M in 2024Q1 to a positive $79.6M in 2026Q2, with the FCF margin fluctuating between -2.7% and 11.9%, demonstrating that top-line growth has not yet translated into a stable cash generation profile.
The FCF trajectory is heavily influenced by the aforementioned working capital volatility rather than consistent operational improvement. While the recent 11.9% FCF margin in 2026Q2 is encouraging, it follows a quarter with negative FCF, making it difficult to ascertain if this represents a new sustainable level. The disconnect between accelerating revenue growth and lumpy free cash flow suggests that the company's expansion may be consuming cash through working capital needs faster than it can generate it from operations.
Working Capital as the Primary Cash Flow Driver
Working capital changes have been the dominant factor in quarterly cash flow, with swings from a $50.7M use of cash in 2026Q1 to a $48.1M source in 2025Q4, indicating that the revenue cycle and payables management are more critical to near-term liquidity than profitability.
The magnitude of these working capital movements, often exceeding net income, points to a business where the efficiency of collecting from government payers and managing vendor payments dictates cash availability. The large negative swings, such as the $45.8M outflow in 2025Q1, may indicate periods of delayed reimbursements or strategic payables management, while large inflows suggest catch-up payments. This dynamic creates a cash flow profile that is inherently unpredictable on a quarterly basis, requiring investors to focus on trailing twelve-month trends rather than single-period results.
Acquisition-Fueled Growth Consumes Cash
Capital deployment has been dominated by acquisition activity, with a net $169.4M outflow in 2026Q2 alone, which appears to be the primary use of the company's operating cash flow and a key reason for its strained balance sheet.
The company's strategy of using cash for acquisitions, as seen in the $169.4M outflow in 2026Q2 and smaller amounts in other quarters, directly competes with debt reduction or shareholder returns. There is no evidence of dividend payments or share repurchases, indicating that all available cash is being reinvested into growth. This aggressive deployment, while driving the reported revenue acceleration, has likely contributed to the elevated leverage profile and leaves little buffer for operational shortfalls or debt service.
Cash Flow Statement Obscures True Leverage
The cash flow statement does not fully capture the company's financial risk, as the significant acquisition activity and volatile working capital mask the underlying cash burn required to service what appears to be a heavy debt load.
While the company reported positive operating cash flow in most quarters, the need to fund large acquisitions suggests that free cash flow after growth investments is minimal or negative. The absence of explicit debt repayment cash flows in the data, combined with the reported high debt/equity ratio, implies that the company may be relying on refinancing or credit facilities to manage its obligations. Furthermore, the stock-based compensation, which peaked at $11.0M in 2025Q1, is a non-cash expense that inflates operating cash flow relative to net income, a nuance that should be considered when assessing true cash earnings.